Clinical Trial Update: Safety and Efficacy of Maytenus Senegalensis for the Treatment of Uncomplicated Malaria [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety and efficacy of Maytenus senegalensis for uncomplicated malaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Maytenus senegalensis

Snippet

Sponsor: Ifakara Health Institute | Conditions: Malaria | Phase 2 | Status: COMPLETED